US EditionClinical Next Generation Sequencing Market Worth US$ 15.2 Bn by 2032
Summary by dpiresearch.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Clinical Next Generation Sequencing Market Worth US$ 15.2 Bn by 2032
Explore the rapidly growing global clinical Next Generation Sequencing (NGS) market, projected to reach USD 6.2 billion by 2024 and surpass USD 15.2 billion by 2032. Discover how advancements in NGS technologies are revolutionizing personalized medicine, enabling efficient diagnostics for cancer, genetic disorders, and infectious diseases. Learn about key market drivers, including declining sequencing costs and investments in genomic research, a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium